Transcription of KDIGO Clinical Practice Guideline for Anemia in …
{{id}} {{{paragraph}}}
OFFICIAL JOURNAL OF THE INTERNATIONAL SOCIETY OF NEPHROLOGY. KDIGO Clinical Practice Guideline for Anemia in chronic Kidney Disease VOLUME 2 | ISSUE 4 | AUGUST 2 2012. 1 7/11/12 12:00 PM. KDIGO Clinical Practice Guideline for Anemia in chronic Kidney Disease KDIGO gratefully acknowledges the following consortium of sponsors that make our initiatives possible: Abbott, Amgen, Bayer Schering Pharma, Belo Foundation, Bristol-Myers Squibb, Chugai Pharmaceutical, Coca-Cola Company, Dole Food Company, Fresenius Medical Care, Genzyme, Hoffmann-LaRoche, JC Penney, Kyowa Hakko Kirin, NATCO The Organization for Transplant Professionals, NKF-Board of Directors, Novartis, Pharmacosmos, PUMC Pharmaceutical, Robert and Jane Cizik Foundation, Shire, Takeda Pharmaceutical, Transwestern Commercial Services, Vifor Pharma, and Wyeth.
KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease v Tables and Figures vi KDIGO Board Members vii Reference Keys viii Abbreviations and Acronyms
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
KDOQI CLINICAL PRACTICE GUIDELINE AND, Kdoqi clinical practice guideline and clinical practice, Chronic, Clinical Practice, Vascular Access Guidelines, Vascular Access, Clinical, Sucrose Administration, Staging, Chronic kidney, Management of Chronic Kidney, Guidelines, Medication Guidelines for Obstetrics and, Medication Guidelines for Obstetrics and Gynaecology, Calcium serum, plasma, blood